학술논문

Drug-Induced Liver Injury Due To Losartan
Document Type
article
Source
European Journal of Case Reports in Internal Medicine (2021)
Subject
losartan
drug-induced liver injury
Medicine
Language
English
ISSN
2284-2594
Abstract
Drug-induced liver injury (DILI) is a challenging diagnosis since a wide variety of medicines can cause adverse reactions. Losartan is an angiotensin II receptor antagonist (ARA-II) approved for the treatment of arterial hypertension. The most common adverse effects are fatigue, anaemia, weakness and cough. An increase in transaminases has been reported with less frequency (